Kester Capital makes Optibrium investment
Kester Capital (Kester) has made an investment in Optibrium, a drug discovery software provider to the pharmaceutical and biotech industries. The business’ customer base includes five of the top ten global pharmaceutical companies. This off-market deal is Kester Capital’s third investment in the Life Sciences sector and follows
